Advertisement

Loading...

C21 Investments Inc.

CXXI.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.38
$-0.02(-5.00%)
Canadian Market opens in 16h 26m

C21 Investments Inc. Fundamental Analysis

C21 Investments Inc. (CXXI.CN) shows moderate financial fundamentals with a PE ratio of -9.60, profit margin of -10.33%, and ROE of -12.42%. The company generates $0.0B in annual revenue with moderate year-over-year growth of 6.48%.

Key Strengths

PEG Ratio0.81

Areas of Concern

ROE-12.42%
Operating Margin7.90%
We analyze CXXI.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 8.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
8.8/100

We analyze CXXI.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

CXXI.CN struggles to generate sufficient returns from assets.

ROA > 10%
-6.26%

Valuation Score

Excellent

CXXI.CN trades at attractive valuation levels.

PE < 25
-9.60
PEG Ratio < 2
0.81

Growth Score

Moderate

CXXI.CN shows steady but slowing expansion.

Revenue Growth > 5%
6.48%
EPS Growth > 10%
-4.67%

Financial Health Score

Excellent

CXXI.CN maintains a strong and stable balance sheet.

Debt/Equity < 1
0.41
Current Ratio > 1
1.32

Profitability Score

Weak

CXXI.CN struggles to sustain strong margins.

ROE > 15%
-1241.52%
Net Margin ≥ 15%
-10.33%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is CXXI.CN Expensive or Cheap?

P/E Ratio

CXXI.CN trades at -9.60 times earnings. This suggests potential undervaluation.

-9.60

PEG Ratio

When adjusting for growth, CXXI.CN's PEG of 0.81 indicates potential undervaluation.

0.81

Price to Book

The market values C21 Investments Inc. at 1.23 times its book value. This may indicate undervaluation.

1.23

EV/EBITDA

Enterprise value stands at 5.36 times EBITDA. This is generally considered low.

5.36

How Well Does CXXI.CN Make Money?

Net Profit Margin

For every $100 in sales, C21 Investments Inc. keeps $-10.33 as profit after all expenses.

-10.33%

Operating Margin

Core operations generate 7.90 in profit for every $100 in revenue, before interest and taxes.

7.90%

ROE

Management delivers $-12.42 in profit for every $100 of shareholder equity.

-12.42%

ROA

C21 Investments Inc. generates $-6.26 in profit for every $100 in assets, demonstrating efficient asset deployment.

-6.26%

Following the Money - Real Cash Generation

Operating Cash Flow

C21 Investments Inc. generates limited operating cash flow of $1.44M, signaling weaker underlying cash strength.

$1.44M

Free Cash Flow

C21 Investments Inc. produces free cash flow of $1.31M, offering steady but limited capital for shareholder returns and expansion.

$1.31M

FCF Per Share

Each share generates $0.01 in free cash annually.

$0.01

FCF Yield

CXXI.CN converts 4.11% of its market value into free cash.

4.11%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-9.60

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.81

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.23

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.99

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.41

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.32

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.12

vs 25 benchmark

ROA

Return on assets percentage

-0.06

vs 25 benchmark

ROCE

Return on capital employed

0.05

vs 25 benchmark

How CXXI.CN Stacks Against Its Sector Peers

MetricCXXI.CN ValueSector AveragePerformance
P/E Ratio-9.6027.91 Better (Cheaper)
ROE-12.42%687.00% Weak
Net Margin-10.33%-45285.00% (disorted) Weak
Debt/Equity0.410.33 Weak (High Leverage)
Current Ratio1.322795.76 Neutral
ROA-6.26%-13557.00% (disorted) Weak

CXXI.CN outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews C21 Investments Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-21.24%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

55.63%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-89.51%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ